GAL-201 as a Promising Amyloid-β-Targeting Small-Molecule Approach for Alzheimer’s Disease Treatment: Consistent Effects on Synaptic Plasticity, Behavior and Neuroinflammation
April 2025, International Journal of Molecular Sciences
Author: MC Services
Small Molecule GAL-201 under development for oral AD treatment: Modulation of Aβ aggregation directly influences synaptic plasticity and also affects neuroinflammation
Written by MC Services on . Posted in Abstracts.
April 2025, AD/PD™ 2025: Advances in Science & Therapy
GAL-101 prevents amyloid beta-induced membrane depolarization in two different types of retinal cells
Written by MC Services on . Posted in References.
January 2025, bioRxiv